Clinical trials
Optic Neuritis trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
29 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 5 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Terminated | 7 |
| Recruiting | 4 |
| Unknown status | 3 |
| Active, not recruiting | 2 |
| Withdrawn | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alexion Pharmaceuticals, Inc. | 4 |
| National Eye Institute (NEI) | 3 |
| Accelerated Cure Project for Multiple Sclerosis | 1 |
| Anastasia Vishnevetsky, MD, MPH | 1 |
| Beth Israel Deaconess Medical Center | 1 |
| EMD Serono | 1 |
| Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecul | 1 |
| Jagannadha R Avasarala | 1 |
| Johns Hopkins University | 1 |
| Mayo Clinic | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Optic Neuritis | 29 |
| Multiple Sclerosis | 16 |
| Neuromyelitis Optica | 10 |
| Myelitis, Transverse | 9 |
| Demyelinating Diseases | 6 |
| Recurrence | 4 |
| Vision Disorders | 3 |
| Myelitis | 2 |
| Neuritis | 2 |
| Optic Neuropathy, Ischemic | 2 |
Trials
Showing 26 to 29 of 29. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.